학술논문
Mirikizumab for the treatment of moderate to severe ulcerative colitis
Document Type
Article
Author
Source
In: Immunotherapy . (Immunotherapy, 1 October 2023, 15(15):1199-1208)
Subject
Language
English
ISSN
17507448
1750743X
1750743X